Guardant Health’s Terilyn J. Monroe sells 3,842 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Guardant Health, Inc. Chief People Officer Terilyn J. Monroe reported direct sales of 3,842 common shares on November 18, 2026 under a Rule 10b5-1 trading plan. The first four reported sale blocks were 500 shares at a weighted-average price of $140.6400 per share, 1,200 at $141.7888, 1,338 at $142.8291, and 704 at $143.6356. The fifth block was 100 shares at $144.5800 per share.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 500 | $140.64 | $70K |
| Sale | Common Stock F2 | 1,200 | $141.7888 | $170K |
| Sale | Common Stock F3 | 1,338 | $142.8291 | $191K |
| Sale | Common Stock F4 | 704 | $143.6356 | $101K |
| Sale | Common Stock | 100 | $144.58 | $14K |
Footnotes (4)
- F1. Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $140.335 to $140.890. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F2. Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $141.385 to $142.310. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3. Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $142.41 to $143.19. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F4. Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $143.420 to $144.115. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
Key Figures
Key Terms
Rule 10b5-1 regulatory
weighted average sales price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.